BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
35.11
-1.29 (-3.54%)
At close: Mar 28, 2025, 4:00 PM
34.91
-0.20 (-0.57%)
After-hours: Mar 28, 2025, 7:16 PM EDT

BridgeBio Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Revenue
221.99.377.6569.728.25
Upgrade
Revenue Growth (YoY)
2285.27%-88.02%11.38%745.14%-79.66%
Upgrade
Cost of Revenue
3.882.453.433.11-
Upgrade
Gross Profit
218.026.8674.2166.68.25
Upgrade
Selling, General & Admin
272.43150.59143.19188.91145.68
Upgrade
Research & Development
506.46455.71399.46451.02337.05
Upgrade
Operating Expenses
778.89606.3542.65639.93482.73
Upgrade
Operating Income
-560.87-599.44-468.44-573.33-474.48
Upgrade
Interest Expense
-99.29-81.29-80.44-46.78-36.66
Upgrade
Interest & Investment Income
17.2518.047.541.134.01
Upgrade
Earnings From Equity Investments
-31.18----
Upgrade
Other Non Operating Income (Expenses)
4.140.3102.433.71.63
Upgrade
EBT Excluding Unusual Items
-669.96-662.4-438.9-615.28-505.49
Upgrade
Merger & Restructuring Charges
-15.61-7.93-43.77--
Upgrade
Gain (Loss) on Sale of Investments
8.1418.31-8.2229.91-
Upgrade
Gain (Loss) on Sale of Assets
178.32-1.24-6.26--
Upgrade
Asset Writedown
----3.3-
Upgrade
Other Unusual Items
-43.09-12.52.21-
Upgrade
Pretax Income
-542.19-653.25-484.65-586.45-505.49
Upgrade
Income Tax Expense
1.15----
Upgrade
Earnings From Continuing Operations
-543.35-653.25-484.65-586.45-505.49
Upgrade
Minority Interest in Earnings
7.5910.053.4723.9256.76
Upgrade
Net Income
-535.76-643.2-481.18-562.54-448.72
Upgrade
Net Income to Common
-535.76-643.2-481.18-562.54-448.72
Upgrade
Shares Outstanding (Basic)
186163147144118
Upgrade
Shares Outstanding (Diluted)
186163147144118
Upgrade
Shares Change (YoY)
14.30%10.39%2.16%22.34%12.27%
Upgrade
EPS (Basic)
-2.88-3.95-3.26-3.90-3.80
Upgrade
EPS (Diluted)
-2.88-3.95-3.26-3.90-3.80
Upgrade
Free Cash Flow
-521.66-529.03-424.32-511.18-407.23
Upgrade
Free Cash Flow Per Share
-2.80-3.25-2.88-3.54-3.45
Upgrade
Gross Margin
98.25%73.71%95.58%95.53%100.00%
Upgrade
Operating Margin
-252.76%-6443.56%-603.28%-822.38%-5751.99%
Upgrade
Profit Margin
-241.44%-6913.92%-619.70%-806.90%-5439.74%
Upgrade
Free Cash Flow Margin
-235.08%-5686.62%-546.46%-733.23%-4936.74%
Upgrade
EBITDA
-554.79-592.95-461.67-567.49-473.03
Upgrade
EBITDA Margin
-250.02%----
Upgrade
D&A For EBITDA
6.086.496.775.841.46
Upgrade
EBIT
-560.87-599.44-468.44-573.33-474.48
Upgrade
EBIT Margin
-252.76%----
Upgrade
Revenue as Reported
----8.25
Upgrade
Advertising Expenses
21.5----
Upgrade
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q